Defective cathepsin Z affects EGFR expression and causes autosomal dominant palmoplantar keratoderma.
Autor: | Malovitski K; Division of Dermatology.; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Sarig O; Division of Dermatology., Feller Y; Division of Dermatology.; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Bergson S; Division of Dermatology.; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Assaf S; Division of Dermatology.; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Mohamad J; Division of Dermatology.; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Pavlovsky M; Division of Dermatology., Giladi M; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Department of Internal Medicine D, Tel Aviv Medical Center, Tel Aviv, Israel., Sprecher E; Division of Dermatology.; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. |
---|---|
Jazyk: | angličtina |
Zdroj: | The British journal of dermatology [Br J Dermatol] 2023 Aug 24; Vol. 189 (3), pp. 302-311. |
DOI: | 10.1093/bjd/ljad167 |
Abstrakt: | Background: The abnormal function of epidermal growth factor receptor (EGFR) has recently been shown to underlie various disorders of cornification. Objectives: To delineate the genetic basis of a novel dominant form of palmoplantar keratoderma (PPK). Methods: Whole-exome (WES) and direct sequencing, quantitative real-time polymerase chain reaction, protein modelling, confocal immunofluorescence microscopy, immunoblotting, three-dimensional skin equivalents and an enzyme activity assay were used to delineate the genetic basis of a novel dominant form of PPK. Results: WES revealed heterozygous variants (c.274T > C and c.305C > T) in CTSZ (encoding cathepsin Z) in four individuals (belonging to three unrelated families) with focal PPK. Bioinformatics and protein modelling predicted the variants to be pathogenic. Previous studies have suggested that EGFR expression may be subject to cathepsin regulation. Immunofluorescence revealed reduced cathepsin Z expression in the upper epidermal layers and concomitant increased epidermal EGFR expression in patients harbouring CTSZ variants. Accordingly, human keratinocytes transfected with constructs expressing PPK-causing variants in CTSZ displayed reduced cathepsin Z enzymatic activity, as well as increased EGFR expression. In line with the role played by EGFR in the regulation of keratinocyte proliferation, human keratinocytes transfected with the PPK-causing variants showed significantly increased proliferation that was abolished upon exposure to erlotinib, an EGFR inhibitor. Similarly, downregulation of CTSZ resulted in increased EGFR expression and increased proliferation in human keratinocytes, suggestive of a loss-of-function effect of the pathogenic variants. Finally, three-dimensional organotypic skin equivalents grown from CTSZ-downregulated cells showed increased epidermal thickness and EGFR expression as seen in patient skin; here, too, erlotinib was found to rescue the abnormal phenotype. Conclusions: Taken collectively, these observations attribute to cathepsin Z a hitherto unrecognized function in epidermal differentiation. Competing Interests: Conflicts of interest The authors declare no conflicts of interest. (© The Author(s) 2023. Published by Oxford University Press on behalf of British Association of Dermatologists. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.) |
Databáze: | MEDLINE |
Externí odkaz: |